Breaking News

Trials & Filings in Brief: Oct. 17, 2013

By Gil Roth | October 17, 2013

AltheRx, AMAG, Discovery Labs, EMD Serono, Pfizer, Relypsa, Savara, Vertex

Phase II
Relypsa HKL treatment reduces serum potassium . . . read more

Savara receives CFFT grant for inhaled antibiotic . . . read more

Phase III
Huge R&D update from Vertex . . . read more

Filings
AltheRx gets patent for OAB combination . . . read more

AMAG PDUFA date delayed . . . read more

Discovery Labs files IND for Aerosurf . . . read more

EMD Serono Gonal-F injector pen approved . . . read more

Pfizer get expanded Prevnar 13 label in EU . . . read more

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important